JWCA
BSX icon

J.W. Cole Advisors’s Boston Scientific BSX Stock Holding History

J.W. Cole Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$294K Buy
+6,896
New +$374K 0.01% 1285
2026
Q1 		– Sell
-8,768
Closed -$747K – 843
2025
Q4 		$747K Buy
8,768
+202
+2% +$19.8K 0.02% 745
2025
Q3 		$836K Sell
8,566
-13,668
-61% -$1.42M 0.02% 788
2025
Q2 		$2.39M Buy
22,234
+14,203
+177% +$1.44M 0.05% 355
2025
Q1 		$810K Buy
8,031
+3,032
+61% +$305K 0.03% 601
2024
Q4 		$447K Buy
4,999
+985
+25% +$86.7K 0.02% 637
2024
Q3 		$336K Buy
4,014
+25
+0.6% +$1.97K 0.01% 739
2024
Q2 		$307K Buy
3,989
+336
+9% +$24.6K 0.01% 695
2024
Q1 		$250K Buy
+3,653
New +$235K 0.01% 756
2020
Q4 		– Sell
-10,265
Closed -$392K – 664
2020
Q3 		$392K Buy
+10,265
New +$396K 0.03% 475

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

J.W. Cole Advisors's BSX Position: Q2 2026 in Review

J.W. Cole Advisors opened a new position in Boston Scientific (BSX) in Q2 2026: 6,896 shares worth $294K. The stake represents 0.01% of the portfolio and ranks #1285 among its holdings. This is a return to the name: J.W. Cole Advisors previously reported a position in BSX as recently as Q4 2025.

J.W. Cole Advisors first reported a position in BSX in Q3 2020 and has held it in 10 quarters since. The position peaked at $2.39M in Q2 2025. 383 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • J.W. Cole Advisors held 6,896 shares of Boston Scientific worth $294K as of Q2 2026.
  • Boston Scientific was a new J.W. Cole Advisors position in Q2 2026.
  • Boston Scientific made up 0.01% of J.W. Cole Advisors's portfolio in Q2 2026, its #1285 holding.
  • J.W. Cole Advisors first reported a position in Boston Scientific in Q3 2020 and has held it in 10 quarters since.
  • J.W. Cole Advisors's Boston Scientific position peaked at $2.39M in Q2 2025.
  • 383 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.